Synlogic Logo (no background).png
Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for Inherited Metabolic Disorders 43rd Annual Meeting
April 01, 2022 07:00 ET | Synlogic, Inc.
CAMBRIDGE, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Synlogic Logo (no background).png
Synlogic Announces Appointment of Michael Jensen as Chief Financial Officer
March 03, 2022 07:00 ET | Synlogic, Inc.
CAMBRIDGE, Mass., March 03, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Synlogic Logo (no background).png
Synlogic To Present at Upcoming Investor and Industry Conferences
February 24, 2022 07:00 ET | Synlogic, Inc.
CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Augusta Fermentation Qualified Opportunity Fund (QOF) Announces First Investment into the Manus Bio Qualified Opportunity Zone Business (QOZB).
November 23, 2020 10:34 ET | Augusta Fermentation QZ, LLC
WAYNE, Pa., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Augusta Fermentation Opportunity Zone Fund I, L.P. (AF I) today announced it has acquired an equity interest in Manus Bio’s QOZB which operates a...
Arzeda.jpg
Arzeda Officially Closes Series A with Total $15.2 Million to Revolutionize Chemical Production with Protein Design
November 28, 2017 14:33 ET | Arzeda
SEATTLE, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Arzeda, The Protein Design CompanyTM, today announced that it has officially closed its Series A funding round with a total investment of $15.2 million. ...
Embracing Open-Source Biotech: DNA Freeware May Out-Innovate Patented Genes
August 27, 2013 07:30 ET | Lux Research
BOSTON, MA--(Marketwired - Aug 27, 2013) - With synthetic biology (synbio) rapidly gaining momentum, and a landmark U.S. Supreme Court judgment striking down an age-old biological patenting system,...